Business Wire

eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada (Newark, NJ, United States - November 8th-9th, 2018) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada" conference has been added to ResearchAndMarkets.com's offering. The international agreement to assemble ...
Business Insider

eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada: In-Depth Review of the Content and Format Requirement - San Francisco, CA, United States - November 14-15, 2019

DUBLIN, Aug. 29, 2019 /PRNewswire/ -- The "eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada" conference has been added to ResearchAndMarkets.com's offering. This two day workshop will ...
Business Wire

eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada: 2-Day Workshop by Ex-FDA Official (Burlingame CA, United States - May 31, 2018 June 1, 2018 ...

DUBLIN--(BUSINESS WIRE)--The "eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada: 2-Day Workshop by Ex-FDA Official" conference has been added to ResearchAndMarkets.com's offering. The ...
Business Insider

eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada: 2-Day Workshop (Burlingame CA, United States - November 14-15, 2019)

Dublin, Oct. 16, 2019 (GLOBE NEWSWIRE) -- The "eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada" conference has been added to ResearchAndMarkets.com's offering. This two day workshop ...
Finanznachrichten

2-Day Workshop by Ex-FDA Official: eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada - Orlando, FL, United States - February 1st-2nd, 2018

The "eCTD Submissions of IND and NDA/BLA to the US FDA, EU and Canada: 2-Day Workshop by Ex-FDA Official" conference has been added to Research and Markets' offering. The international agreement to ...
technologynetworks

Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product

Osiris Therapeutics, Inc. has held a successful pre-Biologics License Application (pre-BLA) meeting for Prochymal used in the treatment of graft-versus-host disease (GvHD). A BLA is a comprehensive ...